News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,954 Results
Type
Article (13647)
Company Profile (110)
Press Release (248197)
Section
Business (88169)
Career Advice (461)
Deals (15359)
Drug Delivery (64)
Drug Development (36826)
Employer Resources (49)
FDA (6280)
Job Trends (6198)
News (150531)
Policy (14067)
Tag
Academia (462)
Alliances (23135)
Alzheimer's disease (350)
Approvals (6271)
Artificial intelligence (59)
Bankruptcy (143)
Best Places to Work (4326)
Biosimilars (39)
Biotechnology (44)
Breast cancer (42)
Cancer (295)
Career advice (405)
Cell therapy (41)
Clinical research (30487)
Collaboration (135)
Compensation (57)
COVID-19 (826)
C-suite (49)
Data (302)
Diabetes (50)
Diagnostics (1250)
Drug pricing (57)
Earnings (31596)
Employer resources (43)
Events (36834)
Executive appointments (152)
FDA (6445)
Funding (92)
Gene therapy (58)
GLP-1 (292)
Government (1285)
Healthcare (3616)
Infectious disease (843)
Inflammatory bowel disease (46)
Interviews (58)
IPO (5839)
Job creations (2050)
Job search strategy (372)
Layoffs (167)
Legal (3415)
Lung cancer (44)
Manufacturing (85)
Medical device (1290)
Medtech (1292)
Mergers & acquisitions (9543)
Metabolic disorders (160)
Neuroscience (446)
NextGen Class of 2024 (1592)
Non-profit (598)
Northern California (408)
Obesity (97)
Opinion (109)
Patents (51)
People (28446)
Pharmaceutical (64)
Phase I (7937)
Phase II (12924)
Phase III (11569)
Pipeline (139)
Podcasts (39)
Policy (44)
Postmarket research (1399)
Preclinical (3219)
Radiopharmaceuticals (117)
Rare diseases (84)
Real estate (2630)
Regulatory (9845)
Research institute (588)
Resumes & cover letters (55)
Southern California (406)
Startups (1626)
United States (3988)
Vaccines (121)
Weight loss (79)
Date
Today (40)
Last 7 days (300)
Last 30 days (1102)
Last 365 days (12727)
2024 (11256)
2023 (14358)
2022 (19741)
2021 (20339)
2020 (19245)
2019 (14956)
2018 (11750)
2017 (13929)
2016 (13146)
2015 (15488)
2014 (12423)
2013 (10592)
2012 (11395)
2011 (11927)
2010 (10890)
Location
Africa (316)
Arizona (39)
Asia (19868)
Australia (2567)
California (940)
Canada (566)
China (106)
Colorado (38)
Connecticut (40)
Europe (38868)
Florida (131)
Illinois (105)
Indiana (82)
Kansas (51)
Maryland (146)
Massachusetts (815)
Minnesota (53)
New Jersey (390)
New York (264)
North Carolina (271)
Northern California (408)
Pennsylvania (266)
South America (501)
Southern California (406)
Texas (123)
Washington State (66)
261,954 Results for "rxi pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging
Phio’s Compound RXI-185 is designed to slow progression of UV induced collagen breakdown
June 18, 2024
·
4 min read
Genetown
Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
Phio Pharmaceuticals Corp. announced that the United States Patent and Trademark Office has granted patent application 17/150,614 for two of its INTASYL Compounds, RXI-185 and RXI-231.
March 6, 2024
·
4 min read
Press Releases
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024
·
8 min read
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
Press Releases
Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
October 28, 2024
·
9 min read
BioMidwest
Aurorium Launches Haelium™ Pharmaceutical Solutions
Aurorium, a specialty ingredients manufacturer and materials innovation partner, is pleased to announce the launch of Haelium™ Pharmaceutical Solutions.
June 25, 2024
·
2 min read
Press Releases
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
November 7, 2024
·
1 min read
Press Releases
Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results
November 6, 2024
·
20 min read
Press Releases
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
October 29, 2024
·
7 min read
1 of 26,196
Next
